ELVN - CIK 0001672619
Enliven Therapeutics, Inc. has filed 750 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (309 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2022-12-29 | 2022-12-28 |
| SEC correspondence | UPLOAD | 2022-12-29 | - |
| Insider trade | 4 | 2022-12-27 | 2022-12-22 |
| Company correspondence | CORRESP | 2022-12-19 | - |
| S-4/A | - | 2022-12-19 | - |
| Insider trade | 4 | 2022-12-12 | 2022-12-08 |
| SEC correspondence | UPLOAD | 2022-12-07 | - |
| 425 | - | 2022-12-05 | - |
| Major company event | 8-K | 2022-12-05 | 2022-11-28 |
| Major company event (amended) | 8-K/A | 2022-11-16 | 2022-11-10 |
| S-4 | - | 2022-11-10 | - |
| Major company event | 8-K | 2022-11-10 | 2022-11-09 |
| Quarterly report | 10-Q | 2022-10-25 | 2022-09-30 |
| Passive ownership stake | SC 13G | 2022-10-24 | - |
| Passive ownership stake | SC 13G | 2022-10-24 | - |
| Insider trade | 4 | 2022-10-24 | 2022-10-20 |
| Proxy materials | DEFA14A | 2022-10-19 | - |
| Insider trade | 4 | 2022-10-19 | 2022-10-17 |
| New insider ownership | 3 | 2022-10-19 | 2022-10-17 |
| 425 | - | 2022-10-14 | - |
| Major company event | 8-K | 2022-10-14 | 2022-10-13 |
| 425 | - | 2022-10-13 | - |
| Major company event | 8-K | 2022-10-13 | 2022-10-13 |
| DEFM14A | - | 2022-10-07 | - |
| PREM14A | - | 2022-09-23 | 2022-09-23 |
| Proxy materials | DEFA14A | 2022-09-07 | - |
| Major company event | 8-K | 2022-09-07 | 2022-09-06 |
| Quarterly report | 10-Q | 2022-08-03 | 2022-06-30 |
| Major company event | 8-K | 2022-07-29 | 2022-07-25 |
| Insider trade | 4 | 2022-06-21 | 2022-06-16 |
| Insider trade | 4 | 2022-06-07 | 2022-06-03 |
| Major company event | 8-K | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Insider trade | 4 | 2022-06-03 | 2022-06-02 |
| Activist ownership stake (update) | SC 13D/A | 2022-05-24 | - |
| Insider trade | 4 | 2022-05-18 | 2022-05-16 |
| Quarterly report | 10-Q | 2022-05-06 | 2022-03-31 |
| Passive ownership stake (update) | SC 13G/A | 2022-04-25 | - |
| Insider trade | 4 | 2022-04-25 | 2022-04-21 |
| New insider ownership | 3 | 2022-04-25 | 2022-04-21 |
| Activist ownership stake (update) | SC 13D/A | 2022-04-25 | - |
| Proxy materials | DEFA14A | 2022-04-22 | - |
| Proxy statement | DEF 14A | 2022-04-22 | 2022-06-02 |
| Passive ownership stake | SC 13G | 2022-04-14 | - |
| Major company event | 8-K | 2022-04-14 | 2022-04-05 |